Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Raptis

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Psycho-Oncology|February 10, 2017
Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimenDonna M Posluszny, Dana H Bovbjerg, Mounzer E Agha, et al.
Oncology Research|March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit LymphomaChristine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
Leukemia Research|February 15, 2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapyDhaval R Mehta, Kenneth A Foon, Robert L Redner, et al.
European Journal of Haematology|March 19, 2015
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplantSara J Lim, Matthew J Lim, Anastasios Raptis, et al.
American Journal of Hematology|December 15, 2015
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplantAya Agha, Alison Sehgal, Matthew J Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Oncology Research|February 24, 2015
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemiaKelly Ross, Amanda L Gillespie-Twardy, Mounzer Agha, et al.
American Journal of Hematology|May 27, 2015
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapySara J Lim, Matthew J Lim, Anastasios Raptis, et al.
Transplantation and Cellular Therapy|December 7, 2021
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and CaregiversDonna M Posluszny, Dana H Bovbjerg, Karen L Syrjala, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 30, 2016
Leukapheresis in patients newly diagnosed with acute myeloid leukemiaVipin Villgran, Mounzer Agha, Anastasios Raptis, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Psycho-Oncology|February 10, 2017
Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimenDonna M Posluszny, Dana H Bovbjerg, Mounzer E Agha, et al.
Oncology Research|March 3, 2016
Flow Cytometric Evaluation of Double/Triple Hit LymphomaChristine G Roth, Amanda Gillespie-Twardy, Stanley Marks, et al.
Leukemia Research|February 15, 2011
Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapyDhaval R Mehta, Kenneth A Foon, Robert L Redner, et al.
European Journal of Haematology|March 19, 2015
Outcome of acute myeloid leukemia patients with pulmonary nodules of uncertain etiology receiving allogeneic hematopoietic progenitor cell transplantSara J Lim, Matthew J Lim, Anastasios Raptis, et al.
American Journal of Hematology|December 15, 2015
Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplantAya Agha, Alison Sehgal, Matthew J Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemiaKenneth A Foon, Michael Boyiadzis, Stephanie R Land, et al.
Oncology Research|February 24, 2015
Intensive chemotherapy in patients aged 70 years or older newly diagnosed with acute myeloid leukemiaKelly Ross, Amanda L Gillespie-Twardy, Mounzer Agha, et al.
American Journal of Hematology|May 27, 2015
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapySara J Lim, Matthew J Lim, Anastasios Raptis, et al.
Transplantation and Cellular Therapy|December 7, 2021
Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and CaregiversDonna M Posluszny, Dana H Bovbjerg, Karen L Syrjala, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 30, 2016
Leukapheresis in patients newly diagnosed with acute myeloid leukemiaVipin Villgran, Mounzer Agha, Anastasios Raptis, et al.
Pageof 6